| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/07/2002 | EP1228194A1 Hematopoietic differentiation of human embryonic stem cells |
| 08/07/2002 | EP1228095A1 Modified gp100 and uses thereof |
| 08/07/2002 | EP1228091A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1227841A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 08/07/2002 | EP1227838A2 Melanoma vaccine and methods of making and using same |
| 08/07/2002 | EP1227837A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227828A1 Viruses for the treatment of cellular proliferative disorders |
| 08/07/2002 | EP1227827A1 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis |
| 08/07/2002 | EP1227826A2 Composition comprising an extract of perna canaliculus, methylsulfonylmethane and glucosamine |
| 08/07/2002 | EP1227825A1 Isolation and expansion of human marrow stromal cells |
| 08/07/2002 | EP1227824A1 Transplant/implant device and method for its production |
| 08/07/2002 | EP1227823A2 Methods for inducing (in vivo) proliferation and migration of transplanted progenitor cells in the brain |
| 08/07/2002 | EP1227822A2 Methods for restoring or enhancing t-cell immune surveillance following naturally or artifically induced immunosuppression |
| 08/07/2002 | EP0825869B1 Pharmaceutical composition comprising lactobacillus plantarum and arginine |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | EP0584245B1 Enzyme systems |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362965A cytoplasmic transfer to de-differentiate recipient cells |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362260A Medicine for treating anal disease and its prepn. |
| 08/07/2002 | CN1362257A Gastrosis treating Chinese medicine prepn. |
| 08/07/2002 | CN1362256A Osteological Chinese medicine prepn. |
| 08/07/2002 | CN1362253A Medicine for increasing leucocyte and its preparation |
| 08/07/2002 | CN1362068A Rheumatoid disease treating capsule |
| 08/07/2002 | CN1362067A Bee glue prepn for treating stomatocase and its compounding process |
| 08/07/2002 | CN1362063A Nanometer polyporus umbrellatus polysaccharide medicine prepn and its prepn process |
| 08/07/2002 | CN1088606C Centrifuger with annular filter |
| 08/07/2002 | CN1088597C Uropoly acid-peptide composition and its usage |
| 08/07/2002 | CN1088595C Traditional Chinese medicinal composition for treating hepatitis and its preparation method |
| 08/07/2002 | CN1088594C Medicine for anti-tubercle bacillus and preparation process thereof |
| 08/07/2002 | CN1088589C Medicine composition for sthenia syndrome treatment of traditional Chinese medical science |
| 08/07/2002 | CN1088570C Food produced from wood frog oil and making method thereof |
| 08/07/2002 | CN1088564C Medicated health tea |
| 08/06/2002 | US6429013 Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
| 08/06/2002 | US6429009 Recombinant retroviral expression vector comprising a replication-defective, nonproducing, interfering, modified human immunodeficiency virus type 1 (hiv-1) f12 proviral genome |
| 08/06/2002 | US6428968 Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject |
| 08/06/2002 | US6428817 Companion animal therapeutic treat |
| 08/06/2002 | US6428802 Cellular interaction at chimeric interface producing interstitial biomaterial with morphological and functional characteristics resembling natural in vivo organ; biocompatability; genitourinary disorder; bladders |
| 08/06/2002 | US6428783 Analyzing bacteria from feces cultures; prophylaxis of irritable bowel syndrome, diarrhea, asthma, fatigue and dermatitis |
| 08/06/2002 | US6428782 Non-myeloablative tolerogenic treatment |
| 08/06/2002 | CA2344954A1 Peptide scaffold encapsulation of tissue cells and uses thereof |
| 08/01/2002 | WO2002059315A2 Human nucleic acids and polypeptides and methods of use thereof |
| 08/01/2002 | WO2002059291A2 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | WO2002059285A1 Methods for immortalizing cells |
| 08/01/2002 | WO2002059279A2 Preparation of replicating kupffer cells and their use in diagnosis and therapy |
| 08/01/2002 | WO2002059278A2 Differentiation of stem cells to pancreatic endocrine cells |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002058750A2 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 08/01/2002 | WO2002058749A2 Carrier with solid fibrinogen and solid thrombin |
| 08/01/2002 | WO2002058735A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | WO2002058729A2 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | WO2002058718A2 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 08/01/2002 | WO2002058712A2 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 08/01/2002 | WO2002043651A3 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease |
| 08/01/2002 | WO2002016620A3 Modulation of stem cell differentiation |
| 08/01/2002 | WO2002004019A3 Use of strains of the parapox ovis virus against organ fibrosis |
| 08/01/2002 | WO2001097820A3 Kefir as a potent anti-oxidant composition |
| 08/01/2002 | WO2001092551A3 Duplexed parvovirus vectors |
| 08/01/2002 | WO2001090315A3 Production of neurons from stem cells |
| 08/01/2002 | WO2001089538A3 Apoptotic entities for use in treatment of endothelium dysfunction disorders |
| 08/01/2002 | WO2001089537A3 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders |
| 08/01/2002 | WO2001089536A3 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders |
| 08/01/2002 | WO2001080633A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/01/2002 | WO2001077157A3 Full-length gb virus c (hepatitis g virus) rna transcripts are infectious in primary cd4 positive t cells and methods of treating hiv |
| 08/01/2002 | WO2001075110A3 Mucin-1 specific binding members and methods of use thereof |
| 08/01/2002 | WO2001070950A3 Antisense nucleic acid molecules targeted to type i collagenase (mmp-1) for inhibition of melanoma invasion |
| 08/01/2002 | WO2001065934A3 Applications of immune system tolerance to treatment of various diseases |
| 08/01/2002 | WO2001012206A3 Soy-glycine extracts and aromatase inhibitors for positively influencing collagen |
| 08/01/2002 | US20020104110 Immunologically privileged cells and uses thereof |
| 08/01/2002 | US20020103475 Implantable bioartificial active sercretion system |
| 08/01/2002 | US20020103343 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 08/01/2002 | US20020103148 Vectors comprising SAR elements |
| 08/01/2002 | US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption |
| 08/01/2002 | US20020102728 Generating cells for treating osteoporosis and osteoarthritis; obtain cells, transform cell with vector coding bone morphogenic protein, recover transformed cells, culture cells |
| 08/01/2002 | US20020102722 Lac shuttle vectors |
| 08/01/2002 | US20020102602 Polypeptide for use as an antitumor agent |
| 08/01/2002 | US20020102537 Retroviral production |
| 08/01/2002 | US20020102529 Storage and maintenance of blood products including red blood cells and platelets |
| 08/01/2002 | US20020102278 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 08/01/2002 | US20020102244 Obtaining a cell sample which contains a stem cell; detecting the expression of BCRP by a cell in the cell sample; wherein a cell that expresses BCRP is identified as a stem cell |
| 08/01/2002 | US20020102241 Useful for the regeneration of damaged kidney tissue, the generation of artificial kidneys and the delivery of transgenes |
| 08/01/2002 | US20020102239 Methods for storing neural cells such that they are suitable for transplantation |
| 08/01/2002 | US20020102238 Reducing oxalate concentrations in an animal by administering formulation comprising a material selected from the group consisting of oxalate-degrading microbes and oxalate-degrading enzymes |
| 08/01/2002 | DE10102229A1 Torfproduktzusammensetzung, Verfahren zu deren Herstellung und Verwendung derselben Torfproduktzusammensetzung, processes for their preparation and use thereof |
| 08/01/2002 | DE10101793A1 Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen Use of SLPI in the treatment of chronic inflammatory bowel disease |
| 08/01/2002 | CA2442602A1 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 08/01/2002 | CA2436139A1 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | CA2436076A1 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 08/01/2002 | CA2435949A1 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | CA2435888A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | CA2435826A1 Differentiation of stem cells to pancreatic endocrine cells |
| 08/01/2002 | CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | CA2333494A1 Blood brain barrier modulation |
| 07/31/2002 | EP1227321A1 Reversible MHC multimer staining for functional purification of antigen-specific T cells |
| 07/31/2002 | EP1227152A1 Bacterial strain and genome of bifidobacterium |
| 07/31/2002 | EP1226826A1 Remedies |
| 07/31/2002 | EP1226274A2 Identification of cells for transplantation |
| 07/31/2002 | EP1226267A1 Process for producing a product containing antihypertensive tripeptides |